Skip to main content
Livermore
Livermore
ZHEN

Invesco Ltd.

SEC CIK
0000914208
Latest filing
Aug 14, 2026

RIGL holding history

Rigel Pharmaceuticals Inc in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings

Shares (Q2 2026)
28,966
Value
$1.13M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of RIGL by Invesco Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628,966$1.13M<0.1%+29+0.1%AddedHolders
Q1 202628,937$782.5K<0.1%−5,984−17.1%ReducedHolders
Q4 202534,921$1.50M<0.1%+6,790+24.1%AddedHolders
Q3 202528,131$797.0K<0.1%+7,796+38.3%AddedHolders
Q2 202520,335$380.9K<0.1%−113,737−84.8%ReducedHolders
Q1 2025134,072$2.41M<0.1%+134,072NewHolders
Q4 20240$00.0%−1,051,355−100.0%Sold outHolders
Q3 20241,051,355$17.0M<0.1%+1,032,755+5,552.4%AddedHolders
Q2 202418,600$152.9K<0.1%+10,050+117.6%AddedConverted for a 1-for-10 splitHolders
Q1 202485,496$126.5K<0.1%+1,026+1.2%AddedHolders
Q4 202384,470$122.5K<0.1%−8,602−9.2%ReducedHolders
Q3 202393,072$100.5K<0.1%+5,276+6.0%AddedHolders
Q2 202387,796$113.3K<0.1%+4,253+5.1%AddedHolders
Q1 202383,543$110.3K<0.1%−85,955−50.7%ReducedHolders
Q4 2022169,498$254.2K<0.1%−4,998,915−96.7%ReducedHolders
Q3 20225,168,413$6.10M<0.1%+8,547+0.2%AddedHolders
Q2 20225,159,866$5.83M<0.1%−1,8510.0%ReducedHolders
Q1 20225,161,717$15.4M<0.1%−4820.0%ReducedHolders
Q4 20215,162,199$13.7M<0.1%−18,748−0.4%ReducedHolders
Q3 20215,180,947$18.8M<0.1%+16,187+0.3%AddedHolders
Q2 20215,164,760$22.4M<0.1%+23,827+0.5%AddedHolders
Q1 20215,140,933$17.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.